Your browser doesn't support javascript.
loading
Design and Preparation of Novel Nitro-Oxide-Grafted Nanospheres with Enhanced Hydrogen Bonding Interaction for O-GlcNAc Analysis.
Wu, Ci; Shi, Song; Hou, Chunyan; Luo, Yang; Byers, Stephen; Ma, Junfeng.
Afiliação
  • Wu C; Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, D.C. 20007, United States.
  • Shi S; Catalysis Center for Energy Innovation, University of Delaware, Newark, Delaware 19716, United States.
  • Hou C; Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, D.C. 20007, United States.
  • Luo Y; Department of Chemistry, Southern University of Science and Technology, Shenzhen 518055, China.
  • Byers S; Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, D.C. 20007, United States.
  • Ma J; Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, D.C. 20007, United States.
ACS Appl Mater Interfaces ; 14(42): 47482-47490, 2022 Oct 26.
Article em En | MEDLINE | ID: mdl-36240223
As an essential modification, O-linked ß-N-acetylglucosamine (O-GlcNAc) modulates the functions of many proteins. However, site-specific characterization of O-GlcNAcylated proteins remains challenging. Herein, an innovative material grafted with nitro-oxide (N→O) groups was designed for high affinity enrichment for O-GlcNAc peptides from native proteins. By testing with synthetic O-GlcNAc peptides and standard proteins, the synthesized material exhibited high affinity and selectivity. Based on the material prepared, we developed a workflow for site-specific analysis of O-GlcNAcylated proteins in complex samples. We performed O-GlcNAc proteomics with the PANC-1 cell line, a representative model for pancreatic ductal adenocarcinoma. In total 364 O-GlcNAc peptides from 267 proteins were identified from PANC-1 cells. Among them, 183 proteins were newly found to be O-GlcNAcylated in humans (with 197 O-GlcNAc sites newly reported). The materials and methods can be facilely applied for site-specific O-GlcNAc proteomics in other complex samples.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Acetilglucosamina / Nanosferas Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Acetilglucosamina / Nanosferas Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article